Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 2
1989 pubmed 73 citations

Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.

Sztein. M B MB; Serrate. S A SA

Key Findings

  • A short 30‑minute pre‑exposure to thymosin‑alpha‑1 enhances IL‑2 secretion and IL‑2 receptor expression after mitogen stimulation
  • Macrophages (or their IL‑1 production) are required after the pre‑exposure for the boost to occur
  • Both CD4+ helper and CD8+ cytotoxic T‑cells respond to thymosin‑alpha‑1

Practical Outcomes

  • Thymosin‑alpha‑1 may act as an immune‑enhancing agent, but the evidence is limited to cell‑culture experiments. Biohackers should treat this as mechanistic insight rather than a dosage guideline, and await human studies before incorporating it into protocols for boosting immunity.

Summary

The study shows that the peptide thymosin‑alpha‑1 can boost the production of the immune signaling molecule IL‑2 and increase its receptor on human immune cells, but only when the cells are briefly exposed to the peptide before being stimulated. This effect needs help from other immune cells that release IL‑1, and it works on both helper and killer T‑cells. The work was done in lab dishes, not in people, so it’s an early clue rather than a ready‑to‑use protocol.

Abstract

Thymosin alpha 1 (T alpha 1) and thymosin fraction 5 (TF5) have been shown to induce lymphocyte maturation and differentiation as well as to modulate mature immune responses to antigens and mitogens. The present study focused on the characterization of the mechanisms involved in T alpha 1 and TF5 enhancement of phytohemagglutinin (PHA)-induced interleukin-2 (IL-2) secretion and interleukin-2 receptor (IL-2R) expression in human mononuclear cells. We provide evidence that TF5 and T alpha 1 modulate an early event(s) during lymphocyte activation by mitogens. A short preincubation period (30 min) of non-adherent cells with thymosins, followed by extensive washing and subsequent exposure to PHA, was sufficient to enhance the production of IL-2 and the expression of IL-2R induced by the mitogen. Furthermore, the concomitant addition of PHA and thymosin during the preincubation period is not necessary for the enhancing effects to occur. We have also studied the role of macrophages on thymosin modulation of these responses. Results presented here indicate that macrophages are not essential for the interaction of thymosins with T-cells. However, macrophages are an absolute requirement during the exposure to the mitogen after preincubation with thymosins for the manifestation of TF5- and T alpha 1-mediated enhancing effects on IL-2 production and IL-2R expression. Human recombinant interleukin-1 beta (rIL-1 beta) was able to replace this macrophage requirement, indicating that production of IL-1 by these cells is a critical event in thymosin modulation of the IL-2 system. Two-color flow cytometric analysis and experiments involving the use of highly purified helper/inducer (Th, CD4+) and cytotoxic/suppressor (Tc, CD8+) T-cell populations indicated that both, Th and Tc cell populations are targets of thymosin activity. These studies provide additional evidence that thymosins play an important role in the modulation of the normal immune response and begin to define the mechanisms underlying T alpha 1 immunoregulatory properties.

Study Information

Provider

pubmed

Year

1989

DOI

10.1016/0192-0561(89)90133-1

Citations

73

References

29